Hemab
Heidi Dyreborg is an experienced finance professional currently serving as a Senior Accountant at Hemab Therapeutics since December 2022. Previously, Heidi held positions as a Senior Finance Assistant at both KemPharm, Inc. and Orphazyme A/S, and worked as an Accounting Assistant at Interdan Bil A/S. Earlier career roles include Regnskabsmedarbejder at Kailow, Kreditorbogholder at Danske Spil A/S, and Senior Accountant AP at ORIGIO, among others. Heidi's career began in the military as a kontor regnskabselev at Flyvestation værløse. Education was completed at Ballerup handelskole from 1989 to 1991.
Hemab
Hemab Therapeutics ApS is an emerging biotech company supported by Novo Holdings A/S with the aim of developing novel treatments for rare and underserved bleeding disorders. Based in Copenhagen, the company is led by a team of drug developers and scientists with deep expertise in haemophilia. Hemab has exclusive licences to state-of-the-art antibody technologies from both Novo Nordisk A/S and Genmab A/S.